Cargando…
Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139056/ https://www.ncbi.nlm.nih.gov/pubmed/32274192 http://dx.doi.org/10.21037/jtd.2019.11.38 |
| _version_ | 1783518681026789376 |
|---|---|
| author | Zhang, Zhenyang Lin, Jiangbo Kang, Mingqiang |
| author_facet | Zhang, Zhenyang Lin, Jiangbo Kang, Mingqiang |
| author_sort | Zhang, Zhenyang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7139056 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71390562020-04-09 Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy? Zhang, Zhenyang Lin, Jiangbo Kang, Mingqiang J Thorac Dis Letter to the Editor AME Publishing Company 2020-03 /pmc/articles/PMC7139056/ /pubmed/32274192 http://dx.doi.org/10.21037/jtd.2019.11.38 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Letter to the Editor Zhang, Zhenyang Lin, Jiangbo Kang, Mingqiang Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy? |
| title | Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy? |
| title_full | Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy? |
| title_fullStr | Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy? |
| title_full_unstemmed | Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy? |
| title_short | Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy? |
| title_sort | neoadjuvant therapy for locally advanced non-small cell lung cancer: tkis or immunotherapy? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139056/ https://www.ncbi.nlm.nih.gov/pubmed/32274192 http://dx.doi.org/10.21037/jtd.2019.11.38 |
| work_keys_str_mv | AT zhangzhenyang neoadjuvanttherapyforlocallyadvancednonsmallcelllungcancertkisorimmunotherapy AT linjiangbo neoadjuvanttherapyforlocallyadvancednonsmallcelllungcancertkisorimmunotherapy AT kangmingqiang neoadjuvanttherapyforlocallyadvancednonsmallcelllungcancertkisorimmunotherapy |